Announcement of Self-Examination on Insider Trading of Company Stock
Shandong Linuo Pharmaceutical Packaging Co., Ltd. (hereinafter referred to as "the Company") held the 19th meeting of the 4th Board of Directors on February 26, 2026, where it reviewed and approved the proposal regarding the "2026 Restricted Stock Incentive Plan (Draft)" and its summary. The specific content can be found in the announcement disclosed by the Company on February 27, 2026, on the Giant Tide Information Network (http://www.cninfo.com.cn).
According to the "Management Measures for Equity Incentives of Listed Companies," "Self-Regulatory Guidelines No. 1 for GEM Listed Companies of Shenzhen Stock Exchange," and other relevant laws, regulations, and normative documents, the Company conducted a self-examination of insider trading activities by insiders of the 2026 restricted stock incentive plan (hereinafter referred to as "the Incentive Plan") within six months prior to the announcement of the draft plan (from August 26, 2025, to February 26, 2026, hereinafter referred to as "the Self-Examination Period") by querying the China Securities Depository and Clearing Corporation Limited Shenzhen Branch (hereinafter referred to as "China Clearing Shenzhen Branch"). The specific situation is as follows: